BAYRY Stock Recent News
BAYRY LATEST HEADLINES
An Australian judge will rule on Thursday on whether Bayer's Roundup weedkiller can cause a type of blood cancer, a closely watched decision that follows some jury verdicts in similar U.S. cases that have found for the plaintiffs.
Bayer (BAYRY) meets the primary goal in the phase III study evaluating the darolutamide/ADT combo without docetaxel in metastatic hormone-sensitive prostate cancer patients.
Bayer said on Wednesday its drug candidate darolutamide was shown to slow the progression of certain types of prostate cancer in a late-stage trial.
WHIPPANY, N.J.--(BUSINESS WIRE)--The Phase III ARANOTE trial, investigating NUBEQA® (darolutamide) plus androgen deprivation therapy (ADT) in patients with metastatic hormone-sensitive prostate cancer (mHSPC), has met its primary endpoint of radiological progression-free survival (rPFS). NUBEQA plus ADT demonstrated a statistically significant and clinically meaningful increase in rPFS compared to placebo plus ADT. Results were consistent with NUBEQA's established safety profile with no new sign.
Bayer's (BAYRY) wholly owned and independently operating subsidiary AskBio started recruitment in the phase II study for Parkinson's disease.
A top Bayer pharmaceutical executive said on Wednesday his group will continue slashing managerial jobs this year, planning cuts in Germany, Japan, the United Kingdom, Belgium and the Netherlands as part of the company's internal reorganization.
WAGENINGEN, Netherlands--(BUSINESS WIRE)--Bayer and Solynta have reached an agreement to collaborate on the commercialization and distribution of true potato seeds in Kenyan and Indian markets. This partnership marks Bayer's entry into the 20 million hectare global potato market and its first collaboration with Solynta, a Dutch company developing robust hybrid potato varieties. The collaboration will center around Solynta's expert knowledge of potato breeding with the development of new robust.
Bayer's crop science division is increasingly turning to artificial intelligence in its battle against crop killing weeds, the company told Reuters.
A Pennsylvania judge on Tuesday slashed a $2.25 billion U.S. verdict against Bayer to $400 million for a Pennsylvania man who said he developed cancer from exposure to the company's Roundup weedkiller.
JEFFERSON CITY, Mo. — After failing in several U.S. states this year, global chemical manufacturer Bayer said Tuesday that it plans to amplify efforts to create a legal shield against a proliferation of lawsuits alleging it failed to warn that its popular weedkiller could cause cancer.